Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
EOG Resources
EOG
$75B
| $52.1M | 0.05% |
559,500
-2,101,300
| -79% | -$195M |
|
|
MODV
477
DELISTED
ModivCare
MODV
| $52M | 0.05% |
907,099
-44,200
| -5% | -$2.86M |
|
|
ATRI
478
DELISTED
Atrion Corp
ATRI
| $51.9M | 0.05% |
60,900
+1,600
| +3% | +$1.41M |
|
479
Linde
LIN
$222B
| $51.8M | 0.05% |
257,800
+75,500
| +41% | +$14.1M |
|
|
BBBY
480
DELISTED
Bed Bath & Beyond Inc
BBBY
| $51.7M | 0.05% |
4,446,560
-776,300
| -15% | -$11.5M |
|
481
CRH
CRH
$65.9B
| $51.6M | 0.05% |
1,575,500
+316,500
| +25% | +$10.3M |
|
482
J&J Snack Foods
JJSF
$1.67B
| $51.5M | 0.05% |
319,800
-74,650
| -19% | -$11.9M |
|
|
Y
483
DELISTED
Alleghany Corp
Y
| $50.9M | 0.04% |
74,788
+27,500
| +58% | +$18.2M |
|
|
PBCT
484
DELISTED
People's United Financial Inc
PBCT
| $50.9M | 0.04% |
3,034,673
+3,700
| +0.1% | +$61.4K |
|
|
NXRT
485
NexPoint Residential Trust
NXRT
$632M
| $50.9M | 0.04% |
1,229,600
-70,900
| -5% | -$2.77M |
|
|
ABB
486
DELISTED
ABB Ltd
ABB
| $50.7M | 0.04% |
2,532,900
-915,700
| -27% | -$17.8M |
|
487
Americold
COLD
$4.19B
| $50.7M | 0.04% |
1,563,100
-1,162,400
| -43% | -$36.8M |
|
|
CSII
488
DELISTED
Cardiovascular Systems, Inc.
CSII
| $50.7M | 0.04% |
1,180,100
+45,200
| +4% | +$1.75M |
|
489
Bread Financial
BFH
$4.46B
| $50.6M | 0.04% |
452,010
+129,686
| +40% | +$15.7M |
|
490
Lantheus
LNTH
$6.59B
| $50.5M | 0.04% |
1,784,300
+348,700
| +24% | +$8.85M |
|
491
Cousins Properties
CUZ
$4.86B
| $50.5M | 0.04% |
1,394,957
+426,739
| +44% | +$16M |
|
492
Bunge Global
BG
$21.5B
| $50.3M | 0.04% |
902,200
-584,700
| -39% | -$31.2M |
|
493
COPT Defense Properties
CDP
$4.19B
| $50.1M | 0.04% |
1,901,607
+748,300
| +65% | +$20.9M |
|
494
Unum
UNM
$14.4B
| $49.9M | 0.04% |
1,488,200
+437,600
| +42% | +$15.2M |
|
495
Energy Transfer Partners
ET
$72B
| $49.9M | 0.04% |
3,541,385
+2,742,100
| +343% | +$40.6M |
|
496
Prudential Financial
PRU
$42.2B
| $49.8M | 0.04% |
493,500
+176,300
| +56% | +$17.6M |
|
497
Alamos Gold
AGI
$14.1B
| $49.7M | 0.04% |
8,214,071
+1,824,900
| +29% | +$9.08M |
|
498
Stride
LRN
$3.26B
| $49.7M | 0.04% |
1,633,300
+49,900
| +3% | +$1.61M |
|
499
NMI Holdings
NMIH
$3.39B
| $49.4M | 0.04% |
1,739,100
-260,200
| -13% | -$7.24M |
|
500
H&R Block
HRB
$6.74B
| $49.1M | 0.04% |
+1,676,000
| New | +$45M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.